We are Nucleating Agent 102 CAS:68308-22-5 manufacturer and supplier in China, Pls send inquiry of to firstname.lastname@example.org of visit www.nbinno.com our official website should you have any interests
SPECIFICATIONS AND PHYSICAL CHARACTERISTICS
|CONTENT OF Ca||%||4±0.50|
PRODUCT FEATURES AND APPLICATIONS
102 powder is a calcium salt of long chain saturated linear carboxylic acids (montanic acids) providing excellent nucleating and lubricating effects in all kinds of injection molded polyamides. In injection molding applications of polyamides the reduction of the cycle time up to 25 % is possible.
Due to the chemical nature 102 powder obtains excellent thermal stability low volatility and color stability.
102 powder does also not affect the transparency and the mechanical properties of polyamides and has no influence on polymer degradation. 102 powder combines the advantages of a lubricating and nucleating agent in one product and is very effective at low concentrations (~ 0.2 – 0.5 %).
Excellent nucleating and lubricating effects in injection molded polyamides
Allows reduction of cycle time up to 25% in injection molding applications
Excellent thermal stability
Low volatility and color stability
Very effective at low concentrations
Combined lubricating and nucleating effect
Can be used already in the polymerisation of polyamides
HANDLING AND STORAGE
Keep container tightly closed and dry and storage in cool place
Related News: The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it.Monoamida del ácido 1,1-ciclohexanodiacético CAS:99189-60-3 As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.3-ethyl-2-oxo-3-phenyl-azetidine-1-carboxylic acid butylamide As a result, the Company’s platform is uniquely capable of overcoming numerous limitations associated with the production of cell therapies using patient- or donor-sourced cells, which is logistically complex and expensive and is subject to batch-to-batch and cell-to-cell variability that can affect clinical safety and efficacy.Cetilistat CAS:282526-98-1 “Standard respiratory support therapies are used to treat the symptoms and wait for the virus to be cleared by itself.”Pharmaceutical intermediates and APIs belong to the fine chemical industry.